LDS/Medical Tests/Biopsy, Skin, Direct Immunofluorescence

Biopsy, Skin, Direct Immunofluorescence

Skin biopsy for immunofluorescence is used to diagnose and distinguish immune-mediated skin disorders such as pemphigus vulgaris, bullous pemphigoid, dermatitis herpetiformis, and systemic lupus erythematosus. The results of immunofluorescence are usually correlated with the results of routine H&E light microscopic analysis. The test involves removing a small portion of a patient’s skin, usually by punch or incisional biopsy, and transporting it to a specialized laboratory for this type of testing. Results of testing will help guide therapy and prognosis.

  • Skin biopsy immunofluorescence testing, either direct or indirect, will help differentiate between certain immune-mediated skin diseases such as pemphigus vulgaris, bullous pemphigoid, dermatitis herpetiformis, and systemic lupus erythematosus.
  • Help guide therapy and prognosis
An interpretive pathology report will be issued.  A specific clinicopathologic diagnosis is determined by the results of skin biopsy immunofluorescence testing, usually in conjunction with routine H&E light microscopic testing.

Normal skin without inflammation, degeneration, or neoplasia.
 

 

A small portion of skin is submitted to a specialized laboratory for direct immunofluorescence testing. For direct testing, the patient’s skin will be exposed to various antibodies and the reactivity, pattern of reactivity (lace-like, granular, linear, or glassy-broad), and location of reactivity (squamous intercellular substance, basement membrane zone, vascular) will be noted. Antibodies include IgG, IgA, IgM, C3 and others. Some patient biopsies will be submitted for the salt-split skin immunofluorescent technique (direct technique).

The location of the biopsy is dictated by the suspected type of skin disorder, e.g., if pemphigus or bullous pemphigoid is suspected, perilesional skin will be taken; if dermatitis herpetiformis is suspected, uninvolved skin 1 cm from a lesion will be sampled; if systemic lupus or discoid lupus, involved skin will be taken; if vasculitis is suspected, skin from a lesion less than 24 hours old will be biopsied. Repeat biopsies may be necessary. Biosies may be submitted fresh on saline-moistened gauze or placed in an appropriate transport medium such as Michele’s solution. Do NOT place in formalin or alcohol.

Contact the testing laboratory for specific instructions before the biopsy procedure.

For more on specimen collection see Directory of Laboratories for methodologies and laboratory specific details.

Indirect immunofluorescence testing, ANA with titer, Immunoperoxidase skin biopsy testing.
Twenty four to seventy-two hours, depending upon transport time.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Esp Rheumatol. 1999; 17(4): 427-32. [PMID: 10464552]
  • Crit Rev Oral Biol Med. 1998; 9(2): 162-78. [PMID: 9603234]
  • Lupus. 1997; 6(2): 145-57. [PMID: 9061663]
  • Autoimmun Rev. 2009 May;8(6):467-73. [PMID: 19162243]
  • Elenitsas R, et al. Lever’s Histopathology of the Skin, 9th ed., Chapter 9. Lippincott Williams & Wilkins: Philadelphia, PA, 243-291.